Mentor Corp. appears in FDA device records as the applicant for P030053, a premarket approval covering MemoryGel silicone gel-filled breast implants. The supplied collection holds two linked PMA records for this applicant, both under the same PMA number: the original approval and one supplement. The records describe a Class III device regulated under 21 CFR 878.3540, with the advisory committee listed as General, Plastic Surgery. [1][2][6]
The approved device and its stated indications
The approval order for P030053 describes MemoryGel silicone gel-filled breast implants and sets out indications covering breast augmentation for women at least 22 years old and breast reconstruction for women of any age, including revision surgery within each category. The Summary of Safety and Effectiveness Data identifies the applicant as Mentor Corporation of Santa Barbara, California, and records a panel recommendation date of April 13, 2005, with notice of approval to the applicant on November 17, 2006. [2][6]
FDA's device record classifies the product as a prosthesis, breast, noninflatable, internal, silicone gel-filled, device class 3, regulation number 878.3540, product code FTR, with medical specialty described as General, Plastic Surgery. [1][2]
Dated filing examples
The original approval, P030053, carries a decision code of APPR and a decision date of November 17, 2006, with a date received of December 12, 2003 and docket number 06M-0492. The supplement P030053/S093 carries a decision code of OK30 and a decision date of October 23, 2026, with a date received of September 25, 2026. [1][2]
The supplement is recorded as a 30-Day Notice with supplement reason Process Change - Manufacturer/Sterilizer/Packager/Supplier, and its approval order statement describes the addition of small size packaging tooling on the existing packaging equipment. The expedited review flag is recorded as N on both records. [1][2]
What the collection counts represent
The supplied collection contains two linked records, both on the PMA pathway, with decision counts of one OK30 and one APPR. The smaller record sample of two entries shows the same split of one OK30 and one APPR. These figures describe the supplied filings as of the snapshot date and are not measures of total company sales, total portfolio or safety performance. [1][2]
No recall records appear in the supplied sample. FDA's breast implant labeling page notes that approved labeling exists both as the version at the time of approval and as current labeling updated with post-approval study information, and the PMA pages caution that a device with supplements may have a changed description, function or indication. [3][10]
Applicant identity and limits of the record
Mentor Corp. is identified here as the FDA legal applicant on these filings. The public documents do not establish a parent company, brand ownership, headquarters, website or commercial status, and the filing address in the device record is not treated as a headquarters. Post-approval study obligations are referenced only generically in the supplied database pages, without study-specific results for this device. [1][5][6]


